RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and acute myeloid leukemia patients

Author： Cao Xueyuan   Mitra Amit K   Pounds Stanley   Crews Kristine R   Gandhi Varsha   Plunkett William   Dolan M Eileen   Hartford Christine   Raimondi Susana   Campana Dario   Downing James   Rubnitz Jeffrey E   Ribeiro Raul C   Lamba Jatinder K  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.14, Iss.12, 2013-09, pp. : 1449-1466

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pharmacogenetics of alkylator-associated acute myeloid leukemia

By Knoche Eric   McLeod Howard L   Graubert Timothy A  

Pharmacogenomics, Vol. 7, Iss. 5, 2006-07 ,pp. : 719-729

Future Medicine

Access to resources Recommend Favorite

Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia

By  

Current Drug Metabolism, Vol. 19, Iss. 1, 2018-03 ,pp. : 55-74

Bentham Science Publishers

Access to resources Recommend Favorite

Triptolide, a Chinese herbal extract, enhances drug sensitivity of resistant myeloid leukemia cell lines through downregulation of HIF-1α and Nrf2

By Chen Feili   Liu Yuejian   Wang Shiyun   Guo Xutao   Shi Pengcheng   Wang Weiguang   Xu Bing  

Pharmacogenomics, Vol. 14, Iss. 11, 2013-08 ,pp. : 1305-1317

Future Medicine

Access to resources Recommend Favorite

RRM1-based tailored chemotherapy for NSCLC?

By  

Inpharma, Vol. 1, Iss. 1432-1433, 2004-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Posttreatment interleukin-2 in patients with acute myeloid leukemia: The end of a long road for patients and clinical trials?

By Grosso Dolores   Weiss Mark A.  

Cancer, Vol. 120, Iss. 7, 2014-04 ,pp. : 940-941

Blackwell Publishing

Access to resources Recommend Favorite